Clinical Trials Directory

Trials / Completed

CompletedNCT01202487

Gluing Lacerations Utilizing Epinephrine

Pretreatment of Lacerations With Topical LET (Lidocaine-Epinephrine-Tetracaine) Reduces Pain During Tissue Adhesive Repair in Children: Double-blind, Randomized, Controlled Trial of Efficacy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
222 (actual)
Sponsor
Children's Hospital of Eastern Ontario · Academic / Other
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

Minor lacerations are a commonly treated injury in the paediatric emergency department . Over the past decade, standard closure of these lacerations has evolved from suture repair to closure with tissue adhesive (also referred to as "skin glue"). Local anaesthetic is not routinely used during application of skin glue as it was with sutures. There are, however, several potential advantages to pre-treating wounds with topical LET (Lidocaine-Epinephrine-Tetracaine), a liquid gel with anaesthetic and vasoconstrictive properties. Some believe LET can improve patient comfort, increase the ease of glue application, and lead to better healing when used on lacerations being repaired with tissue adhesive. This study aims to address the question of whether or not pre-treatment with LET improves outcomes in minor lacerations repaired with skin glue. The primary hypothesis is that pre-treatment of minor lacerations with LET will decrease pain (as measured on a Visual Analog Scale) during repair with tissue adhesive.

Conditions

Interventions

TypeNameDescription
DRUGLET - Lidocaine Epinephrine TetracaineOne time application of 3 cc of Lidocaine Epinephrine Tetracaine Solution at least 45 minutes prior to laceration repair

Timeline

Start date
2011-04-01
Primary completion
2012-01-01
Completion
2012-04-01
First posted
2010-09-16
Last updated
2013-04-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01202487. Inclusion in this directory is not an endorsement.